Advisory Services Network, LLC Cara Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 24, 2021	SELL	$15.07 - $21.71 $15,070 - $21,710	-1,000 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$12.72 - $16.16 $38,160 - $48,480	-3,000 Reduced 75.0%	1,000 $15,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $49,360 - $71,680	4,000 New	4,000 $51,000
Q2 2020 Aug 10, 2020	SELL	$12.39 - $17.33 $12,662 - $17,711	-1,022 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$16.11 - $25.98 $127,252 - $205,216	-7,899 Reduced 88.54%	1,022 $16,000
Q1 2019 May 20, 2019	BUY	$14.41 - $19.64 $4,323 - $5,892	300 Added 3.48%	8,921 $175,000
Q4 2018 Feb 15, 2019	BUY	$12.45 - $23.47 $107,057 - $201,818	8,599 Added 39086.36%	8,621 $112,000
Q3 2018 Nov 02, 2018	BUY	$17.57 - $23.95 $386 - $526	22 New	22 $1,000

826K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $277M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.